Predictive Values of Inflammation-Related Markers and Thyroid Function in Pediatric Thyroid Cancer Patients

Shuo Li, Yihao Liu, Shaoxuan Liu, Gongbo Du, Zipeng Wang, Detao YinFrontiers in Pediatrics 2021 · DOI

TL;DR

This study identifies the neutrophil-to-lymphocyte ratio (NLR) as a promising, non-invasive predictor for pediatric thyroid cancer, outperforming traditional thyroid function tests like TSH. The findings suggest NLR could aid in early diagnosis and risk stratification for this increasingly prevalent childhood cancer.

What Problem Does This Paper Address?

Pediatric thyroid cancer (TC) is on the rise, yet diagnosis and treatment guidelines are often adapted from adult protocols, despite key differences in presentation and pathophysiology. While inflammation is known to play a role in cancer development, and certain blood markers like the neutrophil-to-lymphocyte ratio (NLR) have shown promise in adult TC, their utility in pediatric cases is less understood. Furthermore, the role of thyroid-stimulating hormone (TSH) as a risk factor in pediatric TC remains controversial. This paper aims to bridge this knowledge gap by investigating the predictive value of inflammation-related blood markers and thyroid function in identifying pediatric thyroid cancer.

Methods

The researchers conducted a retrospective study on 270 children with thyroid nodules (TN) over two years. They collected clinical data, including age, gender, thyroid function tests (FT3, FT4, TSH), and inflammation indexes (neutrophils, lymphocytes, platelets). Key inflammation ratios like NLR, LMR, and PLR were calculated. Patients were divided into a thyroid cancer (TC) group and a benign TN group. Statistical analyses included comparisons between groups, binary logistic regression to assess correlations between markers and pathological features, and Receiver Operating Characteristic (ROC) curve analysis to determine the optimal cut-off values for predictive indicators.

Datasets

The study utilized data from 270 pediatric patients with thyroid nodules collected retrospectively from the First Affiliated Hospital of Zhengzhou University between January 2018 and December 2020. This dataset was divided into a malignant thyroid cancer group (n=89) and a benign thyroid nodule group (n=181). No new benchmarks were introduced; the study focused on analyzing existing clinical and laboratory data.

Key Insights and Ideas

  • NLR as a Pediatric TC Sentinel: The study strongly suggests that the NLR, a simple ratio of neutrophils to lymphocytes in the blood, can serve as a valuable, non-invasive indicator for pediatric thyroid cancer. This is particularly important given the need for accessible diagnostic tools in pediatric oncology.
  • TSH's Diminished Role: Contrary to some previous hypotheses, this research refutes the idea that TSH is a significant risk factor or predictor for pediatric thyroid cancer. This finding challenges existing viewpoints and suggests a need to re-evaluate the role of TSH in pediatric TC.
  • Inflammation's Predictive Power: The findings highlight the critical role of systemic inflammation, as reflected by NLR, in the development or presence of pediatric thyroid cancer, even before definitive diagnosis.
  • Subgroup Specificity: The predictive value of NLR was more pronounced in certain subgroups, particularly in older children (14-17 years) and girls, suggesting potential sex and age-related differences in the inflammatory response to thyroid nodules.

Key Results

  • The neutrophil-to-lymphocyte ratio (NLR) showed a significant difference between the thyroid cancer group and the benign thyroid nodule group.
  • An NLR value greater than 1.49529 was identified as a prognostic indicator for pediatric thyroid cancer.
  • Logistic regression analysis confirmed that NLR > 1.49529 is an independent risk factor for pediatric TC.
  • TSH levels did not show a significant difference between the TC and benign TN groups and were not correlated with tumor characteristics in the TC group.
  • ROC analysis for NLR yielded an AUC of 0.610 (p=0.004) with a cut-off value of 1.49529, demonstrating its predictive ability.
  • Other inflammation markers like LMR and PLR, as well as thyroid function tests (FT3, FT4, TSH), did not show significant predictive value in this study.

Limitations and Future Work

The authors acknowledge several limitations:

  • Cross-sectional Design: The study's retrospective nature limits the ability to establish definitive causality.
  • Benign Nodules Diagnosis: Not all benign nodules had definitive pathological or cytological evidence, relying on follow-up for confirmation, which introduces some uncertainty.
  • Confounding Factors: While efforts were made to exclude patients with conditions that could influence leukocytes or thyroid function, other unknown factors might have influenced the results.
  • Single Measurement: Clinical indicators were measured at a single time point, which might not capture dynamic changes.

Future work should focus on multicenter, prospective, and randomized controlled studies to validate these findings and further explore the mechanisms behind the observed relationships. Investigating the dynamic changes in NLR and other markers over time could also provide deeper insights.

Summary updated

Abstract

Few researchers have studied the diagnostic value of inflammation-related hematological indexes of pediatric thyroid carcinoma exclusively. Whether thyroid-stimulating hormone (TSH) is an independent risk factor for pediatric thyroid cancer is still controversial. To assess the correlativity and predictive values of inflammation-related markers and thyroid function in pediatric thyroid cancer patients, we collected a total of 270 children with thyroid nodules for two consecutive years. Clinical data including age, gender, thyroid function, inflammation indexes, and clinical pathologic finding were collected and analyzed. The above-mentioned data were compared between the benign group and the malignant group, followed by the subgroups comparison. Binary logistic regression analysis was used to evaluate the correlation of markers and the pathological features of thyroid nodules. The neutrophil-to-lymphocyte ratio (NLR) showed a significant difference between thyroid cancer and thyroid nodules, while TSH did not. NLR > 1.49529 was the prognostic indicator of pediatric thyroid cancer. The logistic regression model further revealed that NLR > 1.49529 was an independent risk factor for thyroid cancer in pediatric patients. Furthermore, TSH was not correlated with the tumor characteristics in the thyroid cancer group. In conclusion, the findings in this study showed that NLR could be a predictor of thyroid cancer in pediatric patients and refuted the present view that TSH is a risk factor in pediatric thyroid cancer.
BibTeX
@inproceedings{li2021predictive,
  author = {Shuo Li and Yihao Liu and Shaoxuan Liu and Gongbo Du and Zipeng Wang and Detao Yin},
  title = {{Predictive Values of Inflammation-Related Markers and Thyroid Function in Pediatric Thyroid Cancer Patients}},
  booktitle = {Frontiers in Pediatrics},
  year = {2021},
  doi = {10.3389/fped.2021.802214},
}
Figure